NCT01636609 2020-04-13
Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
Phase 1 Terminated
Clinical Trials
4 trialsNCT00780598 2012-06-28
OPAL
Chroma Therapeutics
Phase 2 Completed
NCT01180426 2012-02-15
Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia
Chroma Therapeutics
Phase 2 Unknown
NCT00689000 2010-10-22
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
Chroma Therapeutics
Phase 1/2 Completed